Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
N Isorce, J Lucifora, F Zoulim, D Durantel - Antiviral research, 2015 - Elsevier
Chronic hepatitis B virus (HBV) infection remains a major challenge for clinicians, as there
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
N Isorce, J Lucifora, F Zoulim, D Durantel - Antiviral Research, 2015 - infona.pl
Chronic hepatitis B virus (HBV) infection remains a major challenge for clinicians, as there
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies.
N Isorce, J Lucifora, F Zoulim, D Durantel - Antiviral Research, 2015 - europepmc.org
Chronic hepatitis B virus (HBV) infection remains a major challenge for clinicians, as there
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
N Isorce, J Lucifora, F Zoulim… - Antiviral research, 2015 - pubmed.ncbi.nlm.nih.gov
Chronic hepatitis B virus (HBV) infection remains a major challenge for clinicians, as there
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
N Isorce, J Lucifora, F Zoulim, D Durantel - Antiviral Research, 2015 - hal.science
Chronic hepatitis B virus (HBV) infection remains a major challenge for clinicians, as there
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
[PDF][PDF] Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
N Isorce, J Lucifora, F Zoulim, D Durantel - 2015 - hal.science
Chronic hepatitis B virus (HBV) infection remains a major challenge for clinicians, as there
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …
are only two types of approved therapies: interferon-alpha (IFN-α) or its pegylated form, Peg …